Literature DB >> 15840604

Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent?

A Della Rossa, A Tavoni, G Merlini, C Baldini, M Sebastiani, M Lombardi, D Neglia, S Bombardieri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15840604     DOI： 10.1093/rheumatology/keh661

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  10 in total

1.  Rare association of antiphospholipid syndrome and Takayasu arteritis.

Authors:  Mittermayer B Santiago; Otávio Paz
Journal:  Clin Rheumatol       Date:  2006-03-31       Impact factor: 2.980

Review 2.  Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; J Sieper; P Emery; E C Keystone; M H Schiff; P Mease; P L C M van Riel; R Fleischmann; M H Weisman; M E Weinblatt
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

3.  Novel strategy for the treatment of refractory vasculitis syndrome.

Authors:  Hidehiro Yamada
Journal:  Ann Vasc Dis       Date:  2013-02-15

4.  Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis.

Authors:  Samuel K Shinjo; Rosa M R Pereira; Vivian A P Tizziani; Ari S Radu; Maurício Levy-Neto
Journal:  Clin Rheumatol       Date:  2007-02-28       Impact factor: 2.980

Review 5.  Advances in the use of biologic agents for the treatment of systemic vasculitis.

Authors:  Sharon A Chung; Philip Seo
Journal:  Curr Opin Rheumatol       Date:  2009-01       Impact factor: 5.006

6.  Infliximab therapy in pediatric Takayasu's arteritis: report of two cases.

Authors:  Paola Sabrina Buonuomo; Claudia Bracaglia; Andrea Campana; Antonella Insalaco; Manuela Pardeo; Elisabetta Cortis; Alberto G Ugazio
Journal:  Rheumatol Int       Date:  2009-10-23       Impact factor: 2.631

7.  Biologic agents in systemic vasculitis.

Authors:  Charles F Henderson; Philip Seo
Journal:  Int J Clin Rheumtol       Date:  2011

8.  Takayasu's arteritis treated by percutaneous transluminal angioplasty with stenting in the descending aorta.

Authors:  Byung-Ju Shim; Ho-Joong Youn; Yong-Chul Kim; Woo-Tae Kim; Yun-Seok Choi; Dong-Hyun Lee; Chul- Soo Park; Yong-Seok Oh; Wook-Sung Chung; Jae-Hyung Kim; Kyu-Bo Choi; Soon-Jo Hong; Seung-Eun Jung; Seong-Tai Hahn
Journal:  J Korean Med Sci       Date:  2008-06       Impact factor: 2.153

Review 9.  The role of biological agents in the management of large vessel vasculitis (LVV): a systematic review and meta-analysis.

Authors:  Mohammed Osman; Christian Pagnoux; Donna M Dryden; Dale Storie; Elaine Yacyshyn
Journal:  PLoS One       Date:  2014-12-17       Impact factor: 3.240

10.  Takayasu arteritis presenting as cerebral aneurysms in an 18 month old: A case report.

Authors:  Pamela F Weiss; Diana A Corao; Avrum N Pollock; Terri H Finkel; Sabrina E Smith
Journal:  Pediatr Rheumatol Online J       Date:  2008-01-31       Impact factor: 3.054
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.